Paradigm Biocapital Advisors LP
Top Portfolio Positions
35 positions ·
$4,934,767,608 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| ACLX |
Arcellx, Inc.
Healthcare
|
5,774,016 | $662,972,517 | 13.43% | |
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
6,655,703 | $647,267,116 | 13.12% | |
| NUVL |
Nuvalent, Inc.
Healthcare
|
5,324,433 | $545,488,160 | 11.05% | |
| PCVX |
Vaxcyte, Inc.
Healthcare
|
4,793,020 | $278,522,392 | 5.64% | |
| EWTX |
Edgewise Therapeutics, Inc.
Healthcare
|
7,365,038 | $231,998,697 | 4.70% | |
| GMAB |
Genmab A/S
Healthcare
|
7,967,836 | $213,777,039 | 4.33% | |
| INSM |
INSMED Inc
Healthcare
|
1,254,488 | $205,133,877 | 4.16% | |
| TARS |
Tarsus Pharmaceuticals, Inc.
Healthcare
|
2,562,154 | $179,735,103 | 3.64% | |
| BLTE |
Belite Bio, Inc
Healthcare
|
1,114,784 | $177,741,160 | 3.60% | |
| ERAS |
Erasca, Inc.
Healthcare
|
10,392,702 | $168,153,918 | 3.41% |
Portfolio Trend
18 quarters · across all stocks
Holdings in NUVL
Shares Held
Position Value (USD)
12 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $545,488,160 | 5,324,433 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $530,052,265 | 5,269,433 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $455,700,565 | 5,269,433 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $402,057,737 | 5,269,433 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $373,708,188 | 5,269,433 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $419,845,308 | 5,363,379 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $511,500,000 | 5,000,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $346,807,493 | 4,571,678 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $313,713,254 | 4,177,830 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $283,910,808 | 3,858,008 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $75,305,617 | 1,638,147 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $47,250,009 | 1,120,465 | Shares | Sole | 2023-08-14 | |
| No 13F history on record for this holder in this stock. | ||||||